Psychoeducational Group for Depression

Recruiting N/A Interventional Study
Major Depressive Disorder (MDD
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 59
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
338 (estimated)
Sponsor
Ricardo Alberto Moreno, M.D., Ph.D. · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The study aims to investigate the efficacy of a psychoeducational program as an adjunctive treatment for depression. The study will involve 338 patients diagnosed with Major Depressive Disorder (MDD) of moderate severity. Participants will be randomly assigned to receive either Treatment as usual (TAU) alone or TAU plus the psychoeducational program. The program consists of six weekly group sessio…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion: * Both sexes; * Ages between 18 and 65 years old; * Diagnosis of Major Depressive Disorder (MDD) made by a clinician according to Diagnostic Statistical Manual criteria-5-Text Revised (DSM-5-TR) * Patients with Hamilton Depressive Rating Scale-17 items (HDRS-17) scores 14-23; * Informed …
Contacts

Ricardo A Moreno

55-2661-6648

ricardo.moreno@hc.fm.usp.br

CONTACT